Valneva SE
VALN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001836564
No open-market purchases or sales by Valneva SE insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $19.8M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Valneva SE as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- 0 vs. Q1 2024
- Shares held
- 653.5K
- +202.7K (+45.0%) vs. Q1 2024
- Total value
- $4.73M
- +$1.13M (+31.5%) vs. Q1 2024
- New holders
- 2
- 2 more added
- Sold out
- 2
- 1 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VALN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $19.8M |
| Q1 2026 | 21 | $24.4M |
| Q4 2025 | 19 | $45.8M |
| Q3 2025 | 18 | $64.3M |
| Q2 2025 | 18 | $25.6M |
| Q1 2025 | 14 | $4.53M |
| Q4 2024 | 12 | $3.16M |
| Q3 2024 | 10 | $4.35M |
| Q2 2024 | 11 | $4.73M |
| Q1 2024 | 11 | $3.60M |
| Q4 2023 | 9 | $3.98M |
| Q3 2023 | 10 | $4.69M |
| Q2 2023 | 11 | $5.55M |
| Q1 2023 | 11 | $4.27M |
| Q4 2022 | 10 | $5.16M |
| Q3 2022 | 11 | $4.36M |
| Q2 2022 | 9 | $1.40M |
| Q1 2022 | 11 | $4.70M |
| Q4 2021 | 10 | $6.43M |
| Q3 2021 | 8 | $8.27M |
| Q2 2021 | 9 | $21.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Valneva SE; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| General American Investors Co Inc | 354,361 | $2.60M | 0.19% | 00.0% | Unchanged |
| Wells Fargo & Company | 183,110 | $1.28M | 0.00% | +180,590+7,166.3% | Added |
| AlphaCentric Advisors LLC | 88,252 | $648.7K | 0.48% | +26,248+42.3% | Added |
| Ironwood Investment Management LLC | 25,022 | $175.4K | 0.09% | 00.0% | Unchanged |
| Morgan Stanley | 1,979 | $13.9K | 0.00% | −3,495−63.8% | Reduced |
| Ridgewood Investments LLC | 550 | $3.86K | 0.00% | +550 | New |
| Advisor Group Holdings, Inc. | 150 | $1.05K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 22 | $162 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 7 | $53 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 1 | $7 | 0.00% | +1 | New |
| Royal Bank of Canada | 18 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 0 | $0 | 0.00% | −962−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −200−100.0% | Sold out |